The identification of a calmodulin-binding domain within the cytoplasmic tail of angiotensin-converting enzyme-2

Endocrinology

Volumn 150, Issue 5, 2009, Pages 2376-2381

  Lai, Zon W ^a   Lew, Rebecca A ^a   Yarski, Michael A ^b   Mu, Fi Tjen ^a   Andrews, Robert K ^a   Smith, A Ian ^a  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CALMIDAZOLIUM; CALMODULIN; CALMODULIN BINDING PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTATHIONE TRANSFERASE; PHORBOL ESTER; TRIFLUOPERAZINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; OVARY CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CHEMISTRY; CHO CELL; CRICETULUS; GENETIC TRANSFECTION; GENETICS; HAMSTER; METABOLISM; MOLECULAR GENETICS; PROTEIN PROCESSING; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CALMODULIN; CALMODULIN-BINDING PROTEINS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; CYTOPLASM; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

EID: 66449111167     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1274     Document Type: Article

References (41)

1. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S 2000 A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87:E1-E9
2. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ 2000 A humanhomologofangiotensin-convertingenzyme.Cloningandfunctional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243
3. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM 2002 An- giotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:822-828
4. Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, Lu S, Tikellis C, Grant SL, Lew RA, Smith AI, Cooper ME, Johnston CI 2005 Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 26:369-375; discussion 322-364
5. Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, Canver CC 2003 Increasedangiotensin-(1-7)-formingactivityinfailinghumanheartven- tricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Circulation 108:1707-1712
6. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T,Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM 2005 Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436:112-116
7. Eriksson U, Danilczyk U, Penninger JM 2002 Just the beginning: novel functions for angiotensin-converting enzymes. Curr Biol 12:R745-R752
8. Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, Hooper NM, Turner AJ 2005 Tumor necrosis factor-a convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome- coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). JBiol Chem 280:30113-30119
9. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M 2003 Angioten- sin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454
10. Kahn J, Walcheck B, Migaki GI, Jutila MA, Kishimoto TK 1998 Calmodulin regulates L-selectin adhesion molecule expression and function through a pro- tease-dependent mechanism. Cell 92:809 -818
11. Andrews RK, Suzuki-Inoue K, Shen Y, Tulasne D, Watson SP, Berndt MC 2002 Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. Blood 99:4219-4221
12. Gardiner EE, Arthur JF, Kahn ML, Berndt MC, Andrews RK 2004 Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 104:3611-3617
13. Lambert DW, Clarke NE,Hooper NM, Turner AJ 2008 Calmodulin in teracts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain. FEBS Lett 582:385-390
14. McCutchan JH, Pagano JS 1968 Enhancement of the in fectivity of simianvirus 40 deoxyri bonucleic acid with diethylaminoethyl-dextran. J Natl Cancer Inst 41:351-357
15. Douglas GC, O'Bryan MK, Hedger MP, Lee DK, Yarski MA, Smith AI, Lew RA 2004 The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology 145: 4703-4711
16. Jordan M, Schallhorn A, Wurm FM 1996 Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 24:596-601
17. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P 2002 Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. JBiol Chem 277:14838-14843
18. Dales NA, Gould AE, Brown JA, Calderwood EF, Guan B, Minor CA, Gavin JM, Hales P, Kaushik VK, Stewart M, Tummino PJ, Vickers CS, Ocain TD, Patane MA 2002 Substrate-based design of the first class of angiotensin-con- verting enzyme-related carboxypeptidase (ACE2) inhibitors. J Am Chem Soc 124:11852-11853
19. Erickson-Viitanen S, DeGrado WF 1987 Recognition and characterization of calmodulin-binding sequences in peptides and proteins. Methods Enzymol 139:455-478
20. Andrews RK, Munday AD, Mitchell CA, Berndt MC 2001 Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycopro- tein Ib-IX-V complex. Blood 98:681-687
21. Zuhlke RD, Pitt GS, Deisseroth K, Tsien RW, Reuter H 1999 Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature 399:159-162
22. Lee A, Wong ST, Gallagher D, Li B, Storm DR, Scheuer T, Catterall WA 1999 Ca2 +/calmodulin binds to and modulates P/Q-type calcium channels. Nature 399:155-159
23. Werb Z, Yan Y 1998 A cellular striptease act. Science 282:1279-1280
24. Warner FJ, Lew RA, Smith AI, Lambert DW, Hooper NM, Turner AJ 2005 Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J Biol Chem 280:39353-39362
25. Rice GI, Jones AL, GrantPJ, Carter AM, Turner AJ, Hooper NM 2006 Cir-culating activities of angiotens in-converting enzyme, it shomolog, angiotensin- converting enzyme 2, and neprilysin in a family study. Hypertension 48:914-920
26. Kessler SP, deS Senanayake P, Scheidemantel TS, Gomos JB, Rowe TM, Sen GC 2003 Maintenance of normal blood pressure and renal functions are inependenteffectsofangiotensin-convertingenzyme. JBiolChem278:21105-21112
27. Chattopadhyay S, Santhamma KR, Sengupta S, McCue B, Kinter M, Sen GC, Sen I 2005 Calmodulin binds to the cytoplasmic domain of angiotensin-con- verting enzyme and regulates its phosphorylation and cleavage secretion. JBiol Chem 280:33847-33855
28. James P, Vorherr T, Carafoli E 1995 Calmodulin-binding domains: just two faced or multi-faceted? Trends Biochem Sci 20:38-42
29. O'Neil KT, DeGrado WF 1990 How calmodulin binds its targets: sequence independent recognition of amphiphilic a-helices. Trends Biochem Sci 15:59-64
30. Gnegy ME 1995 Calmodulin: effects of cell stimuli and drugs on cellular activation. Prog Drug Res 45:33-65
31. Crivici A, Ikura M 1995 Molecular and structural basis of target recognition by calmodulin. Annu Rev Biophys Biomol Struct 24:85-116
32. Diaz-Rodriguez E, Esparis-Ogando A, Montero JC, Yuste L, Pandiella A 2000 Stimulation of cleavage of membrane proteins by calmodulin inhibitors. Biochem J 346(Pt 2):359-367
33. Hooper NM, Karran EH, Turner AJ 1997 Membrane protein secretases. Biochem J321(Pt 2):265-279
34. Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T, Nakajima M, Shinohara M, Saya H 2004 Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 165:893-902
35. Pandiella A, Massague J 1991 Multiple signals activate cleavage of the membrane transforming growth factor-a precursor. J Biol Chem 266:5769-5773
36. Shah V, Haddad FG, Garcia-Cardena G, Frangos JA, Mennone A, Groszmann RJ, Sessa WC 1997 Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 100: 2923-2930
37. Shah V, Toruner M, Haddad F, Cadelina G, Papape tropoulos A, Choo K, Sessa WC, Groszmann RJ 1999 Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology 117:1222-1228
38. Wang X, Abdel-Rahman AA 2005 Effect of chronic ethanol administration on hepatic eNOS activity and its association with caveolin-1 and calmodulin in female rats. Am J Physiol 289:G579-G585
39. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, SmithAI, Shaw T, Warner FJ, Zuilli A, Burrell LM, Angus PW 2005 Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54:1790-1796
40. Johnston CI 1994 Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 23:258 -268
41. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, Angus PW 2002 Up-regulation of components of the renin-angiotensin system in the bile duct- ligated rat liver. Gastroenterology 123:1667-1676